Clinical Trials Directory

Trials / Completed

CompletedNCT03507023

Effect of Hibiscus and Lippia Extract on Blood Pressure

Effect of the Combination of Polyphenols Derived From the Hibiscus Sabdariffa and Lippia Citriodora on Slightly Hypertensive or Type 1 Hypertensive Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Universidad Miguel Hernandez de Elche · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Determine if a double-blind, randomized, placebo-controlled clinical intervention, based on a dietetic intervention and physical exercise, supplemented with a polyphenolic extract, decreases blood pressure in hypertensive volunteers.

Detailed description

Slightly hypertensive individuals, before diagnosed with type 1 hypertension, are generally monitored by their physician and given dietetic and physical activity guidelines. The objective of this intervention is to prevent onset of a hypertensive pathologic condition. However, in many cases, this intervention is unsuccessful, and therefore the patient must follow-up with anti-hypertensive drugs. Here, in the current study, the objective is to include a nutritional supplement in the intervention in order to increase the probability of success of the diet/exercise intervention. Previous studies with the supplement Metabolaid has shown the product to significantly decrease the blood pressure of slightly hypertensive individuals. It is estimated, based on the results of previous clinical studies, that the polyphenolic content of the nutritional supplement will reduce at least an additional 10% of the blood pressure of the patients undergoing a diet and exercise intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMetabolaid®500 mg per day, in fasting conditions.
DIETARY_SUPPLEMENTPlacebo500 mg per day, in fasting conditions.

Timeline

Start date
2018-03-26
Primary completion
2019-04-01
Completion
2019-04-15
First posted
2018-04-24
Last updated
2020-09-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03507023. Inclusion in this directory is not an endorsement.